(MENAFN- EIN Presswire)
Spasticity Market
DelveInsight's Spasticity Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM.
LAS VEGAS, NEVADA, UNITED STATES, April 2, 2024 /EINPresswire / -- The Spasticity market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Spasticity pipeline products will significantly revolutionize the Spasticity market dynamics.
DelveInsight's“Spasticity Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Spasticity, historical and forecasted epidemiology as well as the Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Spasticity market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
To Know in detail about the Spasticity market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Spasticity Market Forecast
Some of the key facts of the Spasticity Market Report:
The Spasticity market size was valued approximately USD 904 million in 2021 is anticipated to grow with a significant CAGR during the study period (2019-2032)
Spasticity is one of the most common symptoms of multiple sclerosis (MS) and is defined as muscle stiffness that is frequently generalized and that causes more or less continuous rigidity
There were approximately 2,328,000 prevalent cases of Spasticity in the United States in 2021
According to the analysis, DelveInsight estimated approximately 415,000 prevalent cases of Spasticity in Germany in 2021
Key Spasticity Companies: Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others
Key Spasticity Therapies: Nabiximols, DAXI, IPN10200, and others
The Spasticity epidemiology based on gender analyzed that Males are more at risk of developing Spasticity in comparison to the females
Spasticity Overview
Spasticity is defined as“sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyper excitability of the stretch reflex” or from an upper motor neuron lesion (UMN),presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs
Get a Free sample for the Spasticity Market Report:
Spasticity Market
The dynamics of the Spasticity market are anticipated to change in the coming years owing to the expected launch of emerging therapies such and others during the forecasted period 2019-2032.
“The emerging therapies for the treatment of Spasticity include Nabiximols, DAXI and others. Approval of these therapies will provide new and different treatment options to the patients and will hence drive the market.”
Spasticity Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Spasticity Epidemiology Segmentation:
The Spasticity market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
Total Prevalence of Spasticity
Prevalent Cases of Spasticity by severity
Gender-specific Prevalence of Spasticity
Diagnosed Cases of Episodic and Chronic Spasticity
Download the report to understand which factors are driving Spasticity epidemiology trends @ Spasticity Epidemiological Insights
Spasticity Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spasticity market or expected to get launched during the study period. The analysis covers Spasticity market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Spasticity Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Spasticity Therapies and Key Companies
Nabiximols: Jazz Pharmaceuticals
DAXI: Revance Therapeutics
IPN10200: Ipsen
Scope of the Spasticity Market Report
Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
Key Spasticity Companies: Jazz Pharmaceuticals, Revance Therapeutics, Ipsen, and others
Key Spasticity Therapies: Nabiximols, DAXI, IPN10200, and others
Spasticity Therapeutic Assessment: Spasticity current marketed and Spasticity emerging therapies
Spasticity Market Dynamics: Spasticity market drivers and Spasticity market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Spasticity Unmet Needs, KOL's views, Analyst's views, Spasticity Market Access and Reimbursement
Discover more about therapies set to grab major Spasticity market share @ Spasticity Clinical Trials and Therapeutic Assessment
Table of Contents
1. Spasticity Market Report Introduction
2. Executive Summary for Spasticity
3. SWOT analysis of Spasticity
4. Spasticity Patient Share (%) Overview at a Glance
5. Spasticity Market Overview at a Glance
6. Spasticity Disease Background and Overview
7. Spasticity Epidemiology and Patient Population
8. Country-Specific Patient Population of Spasticity
9. Spasticity Current Treatment and Medical Practices
10. Spasticity Unmet Needs
11. Spasticity Emerging Therapies
12. Spasticity Market Outlook
13. Country-Wise Spasticity Market Analysis (2019–2032)
14. Spasticity Market Access and Reimbursement of Therapies
15. Spasticity Market Drivers
16. Spasticity Market Barriers
17. Spasticity Appendix
18. Spasticity Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Gaurav Bora
DelveInsight Business Research
+1 469-945-7679
email us here
MENAFN02042024003118003196ID1108050102
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.